FutureTech II Acquisition Corp. Files 8-K for Bylaw Amendments

Ticker: FTII · Form: 8-K · Filed: Aug 18, 2025 · CIK: 1889450

Sentiment: neutral

Topics: corporate-governance, bylaws, filing

Related Tickers: FTII

TL;DR

FTII filed an 8-K for bylaw changes and shareholder votes. Keep an eye on governance shifts.

AI Summary

FutureTech II Acquisition Corp. filed an 8-K on August 18, 2025, reporting events as of August 14, 2025. The filing primarily concerns amendments to its articles of incorporation or bylaws, submission of matters to a vote of security holders, and other events. The company, focused on biological products, is incorporated in Delaware and has its fiscal year end on December 31.

Why It Matters

This 8-K filing indicates potential changes in FutureTech II Acquisition Corp.'s corporate governance or structure, which could impact its operations and shareholder rights.

Risk Assessment

Risk Level: low — The filing is procedural and relates to corporate governance updates rather than immediate financial distress or significant operational changes.

Key Players & Entities

FAQ

What specific amendments were made to FutureTech II Acquisition Corp.'s articles of incorporation or bylaws?

The filing indicates that amendments were made, but the specific details of these amendments are not provided in the summary text.

What matters were submitted to a vote of FutureTech II Acquisition Corp.'s security holders?

The filing states that matters were submitted to a vote, but the nature of these matters is not detailed in the provided text.

What are the 'Other Events' reported by FutureTech II Acquisition Corp. on August 14, 2025?

The filing mentions 'Other Events' as a category, but the specific events are not described in the provided summary.

When is FutureTech II Acquisition Corp.'s fiscal year end?

FutureTech II Acquisition Corp.'s fiscal year ends on December 31.

What is the SIC code and industry for FutureTech II Acquisition Corp.?

The SIC code is 2836, and the industry is Biological Products (No Diagnostic Substances).

Filing Stats: 2,499 words · 10 min read · ~8 pages · Grade level 17.5 · Accepted 2025-08-15 18:41:34

Key Financial Figures

Filing Documents

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. FUTURETECH II ACQUISITION CORP. Dated: August 15, 2025 By: /s/ Ray Chek Name: Ray Chen Title: Chief Executive Officer 5

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing